A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of personalized mRNA vaccines to treat the deadly disease. This research comes at a ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit offers insight into the new NCCN guidelines, discusses the new ...

Discover why pancreatic cancer's warning signs often go unnoticed, masquerading as everyday health issues, learn the crucial red flags that shouldn't be ignored ...

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

New blood test PAC-MANN detects pancreatic cancer early with 98% accuracy, offering hope for improved survival rates.

Researchers have developed a simple blood test to detect pancreatic cancer before it spreads to other sites in the body. The ...

Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published ...

The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing ...

The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly ...